A step-by-step risk framework for evaluating micro cap companies ($50M–$500M) before you invest.

Micro caps are where the biggest winners start — but also where the most money gets destroyed. This page exists because these companies deserve a different kind of analysis than established businesses. They don’t have decades of financial history. They don’t have analyst coverage. And the information that does exist is often promotional noise.

This is the framework we use to evaluate them. It won’t tell you what to buy. It will force you to understand what you’re buying and the specific ways you can lose money doing it.

Before You Start: The Instant Disqualifiers

These filters run automatically in our screener. If a company trips any of them, it doesn’t get a page. But if you’re evaluating a micro cap on your own, check these first — they’ll save you hours of research on companies that aren’t worth it.

Reverse stock split in the last 3 years. A reverse split at this stage almost always means the stock was heading toward delisting. Management chose to mask the price decline rather than fix the business. There are rare exceptions (usually post-merger cleanups), but the base rate is terrible.

Shares outstanding growing >20% per year. This means the company is funding itself by selling your ownership stake. Some dilution is normal for pre-revenue companies raising capital. But 20%+ annually means the share printer is running hot, and your slice of any future success is shrinking fast.

Stock-based compensation exceeding 50% of revenue. If more than half of what the company earns goes right back out the door as management compensation, the primary product is paychecks, not innovation.

Sub-$1M revenue with a valuation over $200M. A 200x+ revenue multiple on a company with almost no revenue is pure speculation. The stock price is based entirely on a story, not a business. These occasionally work out, but the odds are stacked against you.

The 7-Step Risk Assessment

Work through these in order. Each step builds on the last. If you can’t answer the questions at any step, that’s information too — it means the company isn’t transparent enough, which is its own red flag.

Step 1: What Does This Company Actually Do?

This sounds obvious, but it’s where most micro cap mistakes start. A lot of these companies have impressive-sounding technology described in language designed to make you feel like you’re investing in the future.

What to look for:

• Can you explain what they sell in one sentence, without jargon?
• Is there a real product that exists today, or is it still in development?
• Who is the customer? Can you name a specific type of buyer?

Where to find it:

• The company’s 10-K filing, specifically the “Business” section (SEC EDGAR)
• Their investor presentation (usually on the IR page of their website)
• NOT their Twitter feed or press releases

The test: If you can’t explain the company to a friend in 30 seconds, you don’t understand it well enough to invest in it.

Step 2: How Big Is the Opportunity?

This is the TAM (total addressable market) question. Every micro cap claims a massive market opportunity. Your job is to figure out if it’s real.

What to look for:

• Does the company cite specific third-party market research for their TAM?
• Is the TAM the whole market, or the slice they can realistically capture?
• Are there existing companies already serving this market? If so, what’s the micro cap’s edge?

How to think about it:

• A $50B TAM means nothing if 5 well-funded competitors are already there
• A $500M niche market with no competition is often more attractive
• “We’re disrupting a trillion-dollar industry” is a marketing line, not analysis

Red flag: The company’s TAM slide shows the entire global market for their category. A medical device company claiming the $12 trillion global healthcare market as their TAM is not being serious with you.

Step 3: Is the Technology Defensible?

Patents, trade secrets, regulatory approvals — these are the moats that protect a micro cap from getting crushed when a bigger company notices their market.

What to look for:

• Patent count and recency. We pull this data automatically from the USPTO PatentsView database. More patents filed recently = actively innovating, not just sitting on old IP.
• Patent quality. Are the patents broad or narrow? Do they cover a core process, or just a minor feature? You can read patent claims on Google Patents.
• Regulatory barriers. FDA approval, FCC licenses, defense clearances — these take years and millions of dollars to obtain, which means competitors can’t just copy the product overnight.
• Trade secrets / proprietary data. Some companies have defensibility through data or processes that can’t be patented. This is harder to evaluate but often mentioned in 10-K risk factors.

Red flag: A tech company with zero patents and no regulatory barriers. If there’s nothing stopping a competitor from building the same thing, the company’s only advantage is a head start — and head starts don’t last.

Step 4: Can They Survive Long Enough to Win?

This is the cash runway question, and it’s the most common way micro cap investors lose money. The technology might be real, the market might be huge, but if the company runs out of money before they get there, the stock goes to zero.

What to look for:

• Cash on hand vs. quarterly burn rate (operating cash flow / 4)
• Runway in months. We calculate this automatically. Under 12 months is dangerous — it means the company will need to raise money soon, which usually means dilution.
• Trend of the burn. Is it getting better (burning less) or worse (burning more)? Check the last 3-4 quarters of operating cash flow.

The math you should do:

Runway = Cash on Hand / (Quarterly Cash Burn)

If the answer is less than 18 months and the company has no clear revenue ramp, they will likely need to raise more money. That means issuing new shares. That means your ownership percentage goes down.

Red flag: A company with 8 months of runway and no revenue growth trajectory. They’re about to become a dilution machine.

Step 5: Is Management Aligned With You?

In micro caps, management quality matters more than almost anything else. A great team can pivot a mediocre product. A bad team will destroy a great one.

What to look for:

• Insider buying. Are executives buying shares with their own money on the open market? This is the strongest signal of conviction. Check SEC Form 4 filings on EDGAR.
• Insider selling. Some selling is normal (executives need to pay taxes and buy houses). But consistent, large-scale selling — especially right after positive press releases — is a terrible sign.
• Compensation structure. What percentage of management comp is salary vs. stock? High stock comp isn’t automatically bad, but it should be tied to performance milestones, not just showing up.
• Track record. Have these executives built companies before? Or are they serial “startup CEOs” who move from one pre-revenue company to the next?

Where to find it:

• SEC EDGAR Form 4 filings (insider transactions)
• The Proxy Statement (DEF 14A) for compensation details
• LinkedIn for career history (yes, really — look at what they did before)

Red flag: A CEO who has led 3 previous micro cap companies, none of which ever achieved profitability, and who is paying themselves $500K+ in salary from a company with $2M in revenue.

Step 6: What Has to Go Right?

Every micro cap investment is a bet that specific things will happen. Your job is to identify exactly what those things are and assess how likely they are.

Common catalysts for micro caps:

• FDA/regulatory approval (binary outcome — huge if yes, devastating if no)
• A major contract award (government, enterprise)
• A product launch with measurable adoption
• A partnership with a larger company
• Hitting a revenue or profitability milestone

What to look for:

• Is there a specific, dated catalyst on the horizon? “We expect FDA approval in Q3 2026” is concrete. “We’re working toward commercialization” is not.
• What happens if the catalyst doesn’t materialize? Does the company have a backup plan, or is it all-or-nothing?
• Has management met previous timelines, or do they have a history of pushing dates back?

Red flag: A company whose entire investment thesis depends on a single event (one FDA decision, one contract) with no fallback. That’s not investing, that’s a coin flip.

Step 7: What Is the Market Pricing In?

This is where most micro cap investors skip straight to — and it should be last, not first. Price only matters after you understand everything above.

What to look for:

• Price-to-Sales ratio compared to peers in the same market tag. A 50x P/S when competitors trade at 10x means the market expects this company to grow 5x faster. Will it?
• Enterprise Value / Revenue is often more useful than P/S for micro caps because it accounts for cash and debt.
• How much of the upside is already priced in? If a company needs to 10x revenue to justify its current price, that’s a high bar.

The framework:

• If the stock is cheap relative to peers AND passes Steps 1-6 → worth deep research
• If the stock is expensive relative to peers BUT passes Steps 1-6 with a strong catalyst → might be worth it, but size the position smaller
• If the stock is expensive AND has red flags → the market is wrong or you’re wrong, and at this size, it’s usually you

How We Score It

Each micro cap on our screener gets a score out of 12, broken into four components:

A score of 12 doesn’t mean “buy.” A score of 3 doesn’t mean “avoid.” The score is a starting point that tells you where to focus your research. A company scoring 2/3 on patents but 0/3 on management quality tells you exactly where the risk is.

What This Framework Cannot Tell You

• Timing. A great micro cap can stay cheap for years. Patience is required.
• Sector-specific risks. Biotech has FDA binary events. Defense has government budget cycles. Clean energy has policy risk. You need to understand the risks specific to each market.
• Black swans. Fraud, key-person risk, sudden regulatory changes — these can’t be screened for.
• Whether you should buy it. This is a risk assessment tool, not investment advice. The decision is always yours.

Position Sizing for Micro Caps

Even if a company passes every step above, micro caps are inherently risky. Some general principles:

No single micro cap should be more than 2-5% of your portfolio. If you’re wrong — and you will be wrong sometimes — it shouldn’t meaningfully damage your overall returns.

The higher the conviction, the larger the position — but never above your ceiling. If a company scores 11/12 and you’ve done deep research, maybe it’s a 5% position. If it’s a 7/12 with an interesting catalyst, maybe it’s 1%.

Averaging down is dangerous in micro caps. Unlike large caps, micro cap declines are often driven by fundamental deterioration (dilution, missed milestones), not temporary market sentiment. Before adding to a losing micro cap position, re-run this entire 7-step assessment. If anything has changed for the worse, don’t throw good money after bad.

This framework is provided for educational purposes only. It is not investment advice. Micro cap stocks carry significant risk of total loss. Always do your own research and consult a financial advisor before making investment decisions.